American Journal of Cardiology
Volume 102, Issue 5 , Pages 593-597 , 1 September 2008

Alcohol Consumption and Heart Failure in Hypertensive US Male Physicians

  • Luc Djoussé, MD, DSc

      Affiliations

    • Division of Aging, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
    • Corresponding Author InformationCorresponding author: Tel: 617:525-7591; Fax: 617-525-7739
  • ,
  • J. Michael Gaziano, MD

      Affiliations

    • Division of Aging, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
    • Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts

Received 28 January 2008 ,Revised 4 April 2008 ,Accepted 4 April 2008.

References 

  1. Mukamal KJ, Muller JE, Maclure M, Sherwood JB, Mittleman MA. Lack of effect of recent alcohol consumption on the course of acute myocardial infarction. Am Heart J. 1999;138:926–933
  2. Aguilar D, Skali H, Moye LA, Lewis EF, Gaziano JM, Rutherford JD, et al Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarction. J Am Coll Cardiol. 2004;43:2015–2021
  3. Walsh CR, Larson MG, Evans JC, Djousse L, Ellison RC, Vasan RS, et al. Alcohol consumption and risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med. 2002;136:181–191
  4. Abramson JL, Williams SA, Krumholz HM, Vaccarino V. Moderate alcohol consumption and risk of heart failure among older persons. JAMA. 2001;285:1971–1977
  5. Bryson CL, Mukamal KJ, Mittleman MA, Fried LP, Hirsch CH, Kitzman DW, et al. The association of alcohol consumption and incident heart failure: the Cardiovascular Health Study. J Am Coll Cardiol. 2006;48:305–311
  6. Djousse L, Gaziano JM. Alcohol consumption and risk of heart failure in the Physicians' Health Study I. Circulation. 2007;115:34–39
  7. Gianoulakis C, Guillaume P, Thavundayil J, Gutkowska J. Increased plasma atrial natriuretic peptide after ingestion of low doses of ethanol in humans. Alcohol Clin Exp Res. 1997;21:162–170
  8. Colantonio D, Casale R, Desiati P, De Michele G, Mammarella M, Pasqualetti P. A possible role of atrial natriuretic peptide in ethanol-induced acute diuresis. Life Sci. 1991;48:635–642
  9. Djousse L, Hunt CS, Eckfeldt JH, Arnett DK, Province MA, Ellison CR. Alcohol consumption and plasma atrial natriuretic peptide (from the HyperGEN Study). Am J Cardiol. 2006;98:628–632
  10. Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med. 1989;321:129–135
  11. Bertolet BD, Freund G, Martin CA, Perchalski DL, Williams CM, Pepine CJ. Unrecognized left ventricular dysfunction in an apparently healthy alcohol abuse population. Drug Alcohol Depend. 1991;28:113–119
  12. Kupari M, Koskinen P, Suokas A. Left ventricular size, mass and function in relation to the duration and quantity of heavy drinking in alcoholics. Am J Cardiol. 1991;67:274–279
  13. McKenna CJ, Codd MB, McCann HA, Sugrue DD. Alcohol consumption and idiopathic dilated cardiomyopathy: a case control study. Am Heart J. 1998;135:833–837
  14. Piano MR. Alcohol and heart failure. J Card Fail. 2002;8:239–246
  15. Nakanishi N, Yoshida H, Nakamura K, Suzuki K, Tatara K. Alcohol consumption and risk for hypertension in middle-aged Japanese men. J Hypertens. 2001;19:851–855
  16. Kromhout D, Bosschieter EB, Coulander CD. Potassium, calcium, alcohol intake and blood pressure: the Zutphen Study. Am J Clin Nutr. 1985;41:1299–1304
  17. Koppes LL, Dekker JM, Hendriks HF, Bouter LM, Heine RJ. Meta-analysis of the relationship between alcohol consumption and coronary heart disease and mortality in type 2 diabetic patients. Diabetologia. 2006;49:648–652
  18. Marmot MG. Alcohol and coronary heart disease. Int J Epidemiol. 2001;30:724–729
  19. Di Castelnuovo A, Rotondo S, Iacoviello L, Donati MB, de Gaetano G. Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation. 2002;105:2836–2844
  20. Di Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, Iacoviello L, de Gaetano G. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med. 2006;166:2437–2445
  21. Gaziano JM, Buring JE, Breslow JL, Goldhaber SZ, Rosner B, VanDenburgh M, et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med. 1993;329:1829–1834
  22. Conigrave KM, Hu BF, Camargo CA, Stampfer MJ, Willett WC, Rimm EB. A prospective study of drinking patterns in relation to risk of type 2 diabetes among men. Diabetes. 2001;50:2390–2395
  23. Djousse L, Biggs ML, Mukamal KJ, Siscovick D. Alcohol consumption and type 2 diabetes among older adults: the Cardiovascular Health Study. Obesity. 2007;15:1758–1765
  24. Imhof A, Woodward M, Doering A, Helbecque N, Loewel H, Amouyel P, et al. Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille). Eur Heart J. 2004;25:2092–2100
  25. Beulens JW, de Zoete EC, Kok FJ, Schaafsma G, Hendriks HF. Effect of moderate alcohol consumption on adipokines and insulin sensitivity in lean and overweight men: a diet intervention study. Eur J Clin Nutr. 2007;Epub 2007 June 6
  26. Beulens JW, van Loon LJ, Kok FJ, Pelsers M, Bobbert T, Spranger J, et al. The effect of moderate alcohol consumption on adiponectin oligomers and muscle oxidative capacity: a human intervention study. Diabetologia. 2007;50:1388–1392
  27. Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, et al Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med. 2004;10:1384–1389
  28. Klag MJ, He J, Mead LA, Ford DE, Pearson TA, Levine DM. Validity of physicians' self-reports of cardiovascular disease risk factors. Ann Epidemiol. 1993;3:442–447

 The Physicians' Health Study was supported by Grants No. CA-34944, CA-40360, and CA-097193 from the National Cancer Institute, Bethesda, Maryland, and Grants No. HL-26490 and HL-34595 from the National Heart, Lung, and Blood Institute, Bethesda, Maryland. Dr. Djoussé is Principal Investigator on a K01 HL-70444 from the National Heart, Lung, and Blood Institute, Bethesda, Maryland.

PII: S0002-9149(08)00761-3

doi: 10.1016/j.amjcard.2008.04.031

American Journal of Cardiology
Volume 102, Issue 5 , Pages 593-597 , 1 September 2008